Dissemin is shutting down on January 1st, 2025

Published in

Thieme Gruppe, Seminars in Respiratory and Critical Care Medicine, 04(44), p. 417-425, 2023

DOI: 10.1055/s-0043-1769614

Links

Tools

Export citation

Search in Google Scholar

The Global Burden of Pleural Diseases

Journal article published in 2023 by Erik Vakil ORCID, Niloofar Taghizadeh, Alain Tremblay
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractPleural diseases include a spectrum of disorders broadly categorized into pneumothorax and pleural effusion. They often cause pain, breathlessness, cough, and reduced quality of life. The global burden of diseases reflects regional differences in conditions and exposures associated with pleural disease, such as smoking, pneumonia, tuberculosis, asbestos, cancer, and organ failure. Disease burden in high-income countries is overrepresented given the availability of data and disease burden in lower-income countries is likely underestimated. In the United States, in 2016, there were 42,215 treat-and-discharge visits to the emergency room for pleural diseases and an additional 361,270 hospitalizations, resulting in a national cost of $10.1 billion.